Skip to main content
. 2021 May 29;5(7):763–769. doi: 10.1002/jgh3.12582

Table 1.

Comparison of clinical characteristics between patients with and without alcoholic liver cirrhosis

Variable Alcoholic LC Non‐alcoholic LC P value
Patients, n (%) 64 (35.4) 117 (64.6)
Man, n (%) 49 (76.6) 68 (58.1) 0.013
Age (years) 61.5 (50.5–70.0) 72.0 (63.5–78.0) <0.001
BMI (kg/m2) 22.8 (21.2–25.5) 23.8 (21.1–26.3) 0.255
Child–Pugh B + C, n (%) 27 (42.2) 29 (24.8) 0.015
HBV/HCV/PBC/Other, n 17/56/11/33
Total bilirubin (mg/dL) 1.0 (0.7–1.4) 0.8 (0.6–1.2) 0.017
Albumin (g/dL) 3.8 (3.4–4.2) 3.9 (3.5–4.3) 0.457
Prothrombin time (%) 74 (62–85) 86 (72–98) <0.001
M2BPGi (C.O.I) 3.16 (1.46–6.82) 2.88 (1.54–5.87) 0.582
BCAA (μmol/L) 394 (320–449) 401 (327–486) 0.210
IGF‐1 (ng/mL) 55 (41–77) 55 (43–72) 0.604
25(OH)D (ng/mL) 11.5 (9.0–16.2) 13.3 (9.7–17.4) 0.265
Zinc (μg/dL) 65 (54–71) 65 (54–75) 0.719
SMI (kg/m2)
All patients 7.32 (6.43–8.11) 6.67 (5.76–7.72) 0.004
Man 7.43 (6.97–8.35) 7.18 (6.62–8.23) 0.414
Woman 6.33 (5.75–6.58) 5.76 (5.03–6.21) 0.014
Handgrip strength (kg)
All patients 30.1 (23.6–36.9) 23.5 (16.6–33.4) 0.001
Man 34.0 (28.1–38.8) 32.0 (24.3–38.0) 0.327
Woman 21.5 (16.5–24.6) 16.4 (14.1–21.1) 0.006
Sarcopenia, n (%) 12 (18.8) 38 (32.5) 0.048
Gait speed (m/s) 1.10 (1.00–1.33) 1.03 (0.79–1.19) 0.006
Slow gait speed, n (%) 14 (21.9) 56 (47.9) 0.001

Values are presented as median (interquartile range) or number (percentage). Statistical analysis was performed using the chi‐squared test or the Mann–Whitney U test, as appropriate.

25(OH)D, 25‐hydroxyvitamin D; BCAA, branched‐chain amino acid; BMI, body mass index; HBV, hepatitis B virus; HCV, hepatitis C virus; IGF‐1, insulin‐like growth factor 1; LC, liver cirrhosis; M2BPGi, Mac‐2 binding protein glycosylation isomer; PBC, primary biliary cholangitis; SMI, skeletal muscle mass index.